注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
台湾神隆股份有限公司是一家主要从事原料药的研发、制造及销售业务的台湾公司。主要产品包括原料药、蛋白药物、寡核苷酸、缩氨酸、针剂制剂、小分子新药及其他化学原料。还从事相关产品的咨询、顾问及生物技术服务业务,产品的国际贸易业务,以及提供化学分子成分的合成、制程开发、商业量产的定制化全程服务。该公司在台湾、美洲、欧洲、澳洲、亚洲等市场销售其产品。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Chih-Hsien Lo | 64 | 2010 | Chairman & General Chief Strategy Officer |
Wei-Te Ho | - | 2012 | Independent Director |
Shiow-Ling Kao | - | 2010 | Representative Director |
Tsung-Ming Su | 64 | 2010 | Representative Director |
Chiou-Ru Shih | - | 2010 | Representative Director |
Tsung-Pin Wu | - | 2015 | Representative Director |
Wen-Chang Chang | - | 2018 | Independent Director |
Lewis Lee | - | 2021 | Independent Director |
Po-Ming Hou | - | 2016 | Representative Director |
Jia-Horng Guo | - | 2017 | Representative Director |
Fu-Jung Lai | - | 2018 | Representative Director |
Li-Tzong Chen | - | 2018 | Independent Director |
Ya-Po Yang | 59 | 2018 | Representative Director |
Chin-Yuan Cheng | - | 2021 | Representative Director |
Ming-Chuan Hsieh | - | 2018 | Representative Director |
Chyun-Yu Yang | - | 2023 | Independent Director |
Ling-Ming Sun | - | 2023 | Representative Director |
Jang-Yang Chang | - | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核